首页> 外文期刊>European journal of human genetics: EJHG >New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update
【24h】

New ZMPSTE24 (FACE1) mutations in patients affected with restrictive dermopathy or related progeroid syndromes and mutation update

机译:患有限制性皮肤病或相关早衰综合征的患者中的新ZMPSTE24(FACE1)突变及其突变更新

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Restrictive dermopathy (RD) is a rare and extremely severe congenital genodermatosis, characterized by a tight rigid skin with erosions at flexure sites, multiple joint contractures, low bone density and pulmonary insufficiency generally leading to death in the perinatal period. RD is caused in most patients by compound heterozygous or homozygous ZMPSTE24 null mutations. This gene encodes a metalloprotease specifically involved in lamin A post-translational processing. Here, we report a total of 16 families for whom diagnosis and molecular defects were clearly established. Among them, we report seven new ZMPSTE24 mutations, identified in classical RD or Mandibulo-acral dysplasia (MAD) affected patients. We also report nine families with one or two affected children carrying the common, homozygous thymine insertion in exon 9 and demonstrate the lack of a founder effect. In addition, we describe several new ZMPSTE24 variants identified in unaffected controls or in patients affected with non-classical progeroid syndromes. In addition, this mutation update includes a comprehensive search of the literature on previously described ZMPSTE24 mutations and associated phenotypes. Our comprehensive analysis of the molecular pathology supported the general rule: complete loss-of-function of ZMPSTE24 leads to RD, whereas other less severe phenotypes are associated with at least one haploinsufficient allele.
机译:限制性皮肤病(RD)是一种罕见且极为严重的先天性皮肤病,其特征是紧实的僵硬皮肤,弯曲部位出现糜烂,多个关节挛缩,骨密度低和肺功能不全,通常导致围产期死亡。在大多数患者中,RD是由复合杂合或纯合ZMPSTE24 null突变引起的。该基因编码金属蛋白酶,特别是参与层粘连蛋白A的翻译后加工。在这里,我们报告了总共16个明确诊断和分子缺陷的家庭。其中,我们报告了7个新的ZMPSTE24突变,这些突变在经典RD或下颌骨发育不良(MAD)受影响的患者中鉴定。我们还报告了9个有1或2个患病儿童的家庭,他们在第9外显子中携带了普通的纯合胸腺嘧啶插入物,证明缺乏创始效应。此外,我们描述了几种新的ZMPSTE24变异体,它们在未受影响的对照中或在患有非经典早衰综合征的患者中鉴定出。另外,该突变更新包括对先前描述的ZMPSTE24突变和相关表型的文献进行全面搜索。我们对分子病理学的综合分析支持以下一般规则:ZMPSTE24的完全功能丧失导致RD,而其他不太严重的表型则与至少一个单倍型等位基因相关。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号